---
schema_version: "secwatch.filing_event.v1"
accession: "0000062709-25-000057"
form_type: "8-K"
ticker: "MRSH"
cik: "0000062709"
company_name: "MARSH & MCLENNAN COMPANIES, INC."
filed_at: "2025-07-09T23:59:59+00:00"
generated_at: "2026-05-18T08:59:08.675091+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Marsh McLennan appoints Bruce Broussard, former Humana CEO, to its Board of Directors

## Summary
- Bruce Broussard, 63, appointed as independent director effective July 9, 2025; Board now has 12 directors.
- He joins the Audit Committee, meeting independence and qualification requirements.
- Broussard served as Humana CEO from 2013-2024 and previously as McKesson Specialty/US Oncology CEO.
- He also serves on boards of HP Inc., Cleveland Clinic, and One Call.

## SEC filing metadata
- accession: 0000062709-25-000057
- form_type: 8-K
- ticker: MRSH
- cik: 0000062709
- company_name: MARSH & MCLENNAN COMPANIES, INC.
- filed_at: 2025-07-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/62709/000006270925000057/0000062709-25-000057-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/62709/000006270925000057/mmc-20250709.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000062709-25-000057
- JSON: https://secwatch.observer/filing/0000062709-25-000057.json
- Plain text: https://secwatch.observer/filing/0000062709-25-000057.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
